Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sjögren's syndrome.

Nicolas Delaleu1, Roland Jonsson, Markus M Koller

  • 1Clinic for Geriatric and Special Care Dentistry, University of Zürich, Zürich, Switzerland. nicolas.delaleu@gades.uib.no

European Journal of Oral Sciences
|April 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial gene expression of salivary glands in Sjögren's disease highlights T follicular helper cell signalling as an indicator of disease pathogenesis.

RMD open·2026
Same author

A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's disease.

Annals of the rheumatic diseases·2025
Same author

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).

Annals of the rheumatic diseases·2025
Same author

2023 International Rome consensus for the nomenclature of Sjögren disease.

Nature reviews. Rheumatology·2025
Same author

Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.

Annals of the rheumatic diseases·2025
Same author

Kynurenines and neopterin are interferon-gamma-inducible biomarkers for Sjögren's disease.

Rheumatology (Oxford, England)·2025
Same journal

The emerging role of piRNAs in periodontal and orthodontic tissue dynamics: Biological insights and clinical perspectives-A review.

European journal of oral sciences·2026
Same journal

The speed of innovation versus the speed of validation: A growing governance gap in contemporary endodontics.

European journal of oral sciences·2026
Same journal

Effect of bioactive dentin modulators on adhesion of glass fiber posts.

European journal of oral sciences·2026
Same journal

Does the 2018 periodontal classification improve patient understanding? A missing piece in periodontal care.

European journal of oral sciences·2026
Same journal

Esthetic and adhesive properties of a novel colored fiber post: A restorative approach to an endodontic challenge.

European journal of oral sciences·2026
Same journal

Deep-layer integrity in bulk restorations: Effects of placement technique on fiber- and particulate-reinforced bulk-fill composites properties.

European journal of oral sciences·2026
See all related articles

Sjögren's syndrome (SS) is an autoimmune disease affecting exocrine glands. Research suggests autoimmune responses, potentially involving autoantibodies and B-cell dysfunction, contribute to SS pathogenesis and symptoms.

Area of Science:

  • Immunology
  • Rheumatology
  • Pathophysiology

Background:

  • Sjögren's syndrome (SS) is a chronic autoimmune disorder targeting exocrine glands, notably salivary and lacrimal glands.
  • The precise etiology of SS remains unclear, with ongoing investigation into potential environmental triggers in genetically susceptible individuals.
  • Glandular dysfunction and sicca symptoms in SS may stem from altered apoptosis and cellular processes preceding overt gland destruction.

Purpose of the Study:

  • To explore the immunological underpinnings of Sjögren's syndrome.
  • To investigate the role of T- and B-cell populations in SS pathogenesis.
  • To elucidate potential mechanisms contributing to salivary secretion deficiency and B-cell abnormalities in SS.

Main Methods:

  • Analysis of T- and B-cell populations within affected salivary and lacrimal glands.

Related Experiment Videos

  • Review of recent reports on autoantibodies and their potential role in inhibiting neuronal innervation and water transport.
  • Examination of B-cell activating factor studies concerning apoptosis and B-cell maturation.

    • Main Results:

    • Unique T- and B-cell populations are identified in the glands of SS patients.
    • Autoantibodies targeting neuronal innervation and defective water transport are implicated in reduced salivary secretion.
    • Diminished apoptosis and aberrant B-cell maturation may lead to autoreactive B-cells and B-cell hyperreactivity.

    Conclusions:

    • The pathogenesis of Sjögren's syndrome involves complex autoimmune responses, including specific T- and B-cell dysregulation.
    • Autoantibodies and impaired B-cell regulation are key factors in SS, potentially leading to glandular dysfunction and increased lymphoma risk.
    • Further research is needed to fully understand the mechanisms of tolerance breakdown and the precise triggers in SS.